Royal Capital Wealth Management LLC Decreases Stock Position in CME Group Inc. (NASDAQ:CME)

Royal Capital Wealth Management LLC cut its stake in CME Group Inc. (NASDAQ:CME) by 14.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,100 shares of the financial services provider’s stock after selling 848 shares during the quarter. Royal Capital Wealth Management LLC’s holdings in CME Group were worth $1,003,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CME. Bluefin Capital Management LLC purchased a new stake in shares of CME Group in the fourth quarter worth approximately $2,891,000. Alaska Permanent Fund Corp lifted its position in shares of CME Group by 81.4% during the first quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock worth $9,588,000 after purchasing an additional 19,985 shares during the last quarter. Bank of Nova Scotia boosted its stake in shares of CME Group by 229.4% during the fourth quarter. Bank of Nova Scotia now owns 292,597 shares of the financial services provider’s stock valued at $61,618,000 after purchasing an additional 203,769 shares during the period. Oak Harvest Investment Services grew its holdings in shares of CME Group by 66.5% in the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after purchasing an additional 18,017 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its stake in CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after buying an additional 8,443 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Trading Up 1.1 %

Shares of NASDAQ CME opened at $218.16 on Wednesday. The business has a fifty day moving average price of $208.65 and a 200 day moving average price of $207.41. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $78.55 billion, a P/E ratio of 24.82, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue was up 12.7% compared to the same quarter last year. During the same period last year, the business earned $2.30 EPS. Equities research analysts expect that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is presently 52.33%.

Analyst Ratings Changes

CME has been the subject of several research reports. Piper Sandler reissued an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a research report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft boosted their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Barclays raised their price objective on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Bank of America lowered CME Group from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $209.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.